17-allylamino-17-demethoxygeldanamycin polymorphs and formulations
US7648976B2 · kind B2 · utility
0Cited by
9References
47Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 8, 2006 |
| Grant date | Jan 19, 2010 |
| Priority date | — |
| Expiry date | Feb 24, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Polymorphs and pharmaceutical formulations of 17-allylamino-17-demethoxygeldanamycin (17-AAG).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.